Skip to content

Nutrition and Physical Exercise Study

Influence of a Combined Intervention by Nutritional Support and Physical Exercise on Quality of Life in Cancer Out-patients Treated in Palliative Intention.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01540968
Enrollment
58
Registered
2012-02-29
Start date
2012-03-31
Completion date
2015-03-31
Last updated
2015-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Cancer, Lung Cancer

Brief summary

The purpose of this study is to investigate the effect of a combined treatment of nutritional therapy and physical exercise in palliative cancer out-patients. The investigators hypothesize that this combined intervention consisting of an increased energy- and protein intake and physical exercise level improves quality of life (QoL), functional and clinical status.

Interventions

BEHAVIORALNutrition & physical exercise

Patients will be randomly assigned to intensive individual nutritional counselling including oral nutritional supplements and a specifically designed exercise program combining strength and balance training.

Sponsors

Kantonsspital Winterthur KSW
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Histologically or cytologically confirmed metastatic lung cancer or gastrointestinal cancer * WHO performance status 0, 1 or 2 * Able to walk at least 100 meters independently without crutches or walking frame assessed by the treating physician on the basis of the patient's history and physical condition * Receiving palliative treatment

Exclusion criteria

* Enteral and/or parenteral nutrition within 1 month previous to study participation * History of ileus within one month * Known brain metastases or symptomatic bone metastases * Psychiatric disorder precluding understanding of information on trial related topics and giving informed consent. * Any serious underlying medical condition which could impair the ability of the patient to participate in the trial

Design outcomes

Primary

MeasureTime frame
Quality of life3 months

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026